Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-13 4:05 pm Sale | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | 3i LP | 301,000 4.990% | -17,823 (-5.59%) | View |
| 2024-03-04 4:07 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | Boswell Prayer Ltd. | 471,592 8.200% | 471,592 (New Position) | View |
| 2024-03-01 5:19 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | Benuvia Operations LLC | 384,226 6.700% | 384,226 (New Position) | View |
| 2024-03-01 5:16 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | Aperture Healthcare Ventures Ltd. | 444,070 7.700% | 444,070 (New Position) | View |
| 2024-03-01 5:13 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | AME Equities LLC | 369,177 6.400% | 369,177 (New Position) | View |
| 2024-03-01 5:10 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | Motif Pharmaceuticals Ltd. | 483,406 8.400% | 483,406 (New Position) | View |
| 2024-03-01 5:07 pm Purchase | 13G | CHANNEL THERAPEUTICS CORPORATI CHRO | 3i LP | 318,823 5.500% | 318,823 (New Position) | View |
| 2024-02-26 6:36 pm Purchase | 13D | CHANNEL THERAPEUTICS CORPORATI CHRO | Friedberg Ezra M | 545,721 9.500% | 545,721 (New Position) | View |